# Artichoke Leaf Cholesterol Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/artichoke-leaf-cholesterol-randomized-trial-evidence-review
Category: evidence-review
Summary: Artichoke Leaf Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-07-30
Reviewed by: Migaku Evidence Review
# Artichoke Leaf Cholesterol Randomized Trial: What the Evidence Says

## Quick Answer

Artichoke Leaf Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation | research article | 4 | 2025-11-24 | 10.3390/nu17233674 |
| Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels | research article | 4 | 2025-08-09 | 10.3390/biomedicines13081948 |

## What The Sources Report

- Helicobacter pylori 1 2 3 4 2 Health conditions associated with stomach acid include gastroesophageal reflux disease (GERD), esophagitis, dyspepsia, chronic gastritis, gastric and duodenal ulcers, andinfection. [Teterovska Renāte (2025); evidence level 4]
- A potential alternative approach is the use of herbal medicinal products (HMPs) and food supplements (FSs) for the prevention and treatment of diseases and symptoms associated with increased stomach acid. [Teterovska Renāte (2025); evidence level 4]
- Low-density lipoprotein cholesterol (LDL-C) increases cardiovascular risk, whereas high-density lipoprotein cholesterol (HDL-C) decreases it. [Vitulano Nicola (2025); evidence level 4]
- Clinical evidence supports the effectiveness of lowering LDL-C to prevent cardiovascular events. [Vitulano Nicola (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For artichoke leaf cholesterol randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Teterovska Renāte (2025). Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical Assessment of Health Claims on Gastric Acid Regulation. DOI: 10.3390/nu17233674. PMCID: PMC12693992. PMID: 41373965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12693992/
- Vitulano Nicola (2025). Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels. DOI: 10.3390/biomedicines13081948. PMCID: PMC12383404. PMID: 40868202. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12383404/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.